{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:45:26Z","timestamp":1770331526902,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973286"],"award-info":[{"award-number":["81973286"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973393"],"award-info":[{"award-number":["81973393"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8247132760"],"award-info":[{"award-number":["8247132760"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.tiv.2025.106063","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T21:34:54Z","timestamp":1744666494000},"page":"106063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Species differences in microsomal metabolism of hydroxychloroquine"],"prefix":"10.1016","volume":"107","author":[{"given":"Guilin","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaohua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2025.106063_bb0005","article-title":"Exploring the impact of COVID-19 on tourism: transformational potential and implications for a sustainable recovery of the travel and leisure industry","volume":"2","author":"Abbas","year":"2021","journal-title":"Curr. Res. Behav. Sci."},{"issue":"6","key":"10.1016\/j.tiv.2025.106063_bb0010","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/jac\/dkv018","article-title":"Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases","volume":"70","author":"Al-Bari","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.tiv.2025.106063_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2133\/dmpk.DMPK-10-RV-089","article-title":"Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism","volume":"26","author":"Baillie","year":"2011","journal-title":"DMPK"},{"issue":"7","key":"10.1016\/j.tiv.2025.106063_bb0020","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/dmd.31.7.815","article-title":"The conduct of in vitro and in vivo drug-drug interaction studies: a pharmaceutical research and manufacturers of America (PhRMA) perspective","volume":"31","author":"Bjornsson","year":"2003","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.tiv.2025.106063_bb0025","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1590\/S1984-82502009000400008","article-title":"Enantioselective metabolism of hydroxychloroquine employing rats and mice hepatic microsomes","volume":"45","author":"Cardoso","year":"2009","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2025.106063_bb0030","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jchromb.2017.11.026","article-title":"Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC\u2013ESI\u2013MS\/MS: an application for pharmacokinetic studies","volume":"1072","author":"Chhonker","year":"2018","journal-title":"J. Chromatogr. B"},{"issue":"1","key":"10.1016\/j.tiv.2025.106063_bb0035","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1038\/s41598-021-86321-z","article-title":"Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice","volume":"11","author":"Choi","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.tiv.2025.106063_bb0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1124\/jpet.117.245639","article-title":"Hydroxychloroquine: a physiologically-based pharmacokinetic model in the context of cancer-related autophagy modulation","volume":"365","author":"Collins","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.tiv.2025.106063_bb0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/clpt.2011.287","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype","volume":"91","author":"Crews","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.tiv.2025.106063_bb0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/15563650.2020.1817479","article-title":"Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose","volume":"59","author":"Doyno","year":"2021","journal-title":"Clin. Toxicol."},{"issue":"2","key":"10.1016\/j.tiv.2025.106063_bb0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40744-015-0012-0","article-title":"Pharmacokinetics and bioequivalence study of hydroxychloroquine sulfate tablets in Chinese healthy volunteers by LC-MS\/MS","volume":"2","author":"Fan","year":"2015","journal-title":"Rheumatol. Ther."},{"key":"10.1016\/j.tiv.2025.106063_bb0060","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1177\/0961203396005001041","article-title":"Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases","volume":"5","author":"Furst","year":"1996","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.tiv.2025.106063_bb0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.tox.2008.09.002","article-title":"Induction of drug metabolism: species differences and toxicological relevance","volume":"254","author":"Graham","year":"2008","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.tiv.2025.106063_bb0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tips.2004.02.007","article-title":"Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future","volume":"25","author":"Ingelman-Sundberg","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.tiv.2025.106063_bb0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00280-002-0453-3","article-title":"Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA","volume":"49","author":"Jacobson","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"11","key":"10.1016\/j.tiv.2025.106063_bb0080","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1016\/j.cclet.2020.05.038","article-title":"Sensing cytochrome P450 1A1 activity by a resorufin-based isoform-specific fluorescent probe","volume":"31","author":"Jin","year":"2020","journal-title":"Chin. Chem. Lett."},{"issue":"7","key":"10.1016\/j.tiv.2025.106063_bb0085","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1124\/dmd.114.057778","article-title":"The metabolic drug-drug interaction profile of Dabrafenib: in vitro investigations and quantitative extrapolation of the P450-mediated DDI risk","volume":"42","author":"Lawrence","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2025.106063_bb0090","first-page":"6830459","article-title":"Pharmacokinetics and toxicokinetics of artemisinin-hydroxychloroquine sulfate tablets in rats and dogs","volume":"1","author":"Li","year":"2021","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.tiv.2025.106063_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.602880","article-title":"Time-dependent distribution of hydroxychloroquine in cynomolgus macaques using population pharmacokinetic modeling method","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.tiv.2025.106063_bb0100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","author":"Martignoni","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"1A","key":"10.1016\/j.tiv.2025.106063_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(83)91265-2","article-title":"Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate","volume":"75","author":"McChesney","year":"1983","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.tiv.2025.106063_bb0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.bjp.0704101","article-title":"HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme","volume":"133","author":"Miyata","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.tiv.2025.106063_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106057","article-title":"Cardiac effects and toxicity of chloroquine: a short update","volume":"56","author":"Mubagwa","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.tiv.2025.106063_bb0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/dmd.122.001018","article-title":"Hydroxychloroquine is metabolized by cytochrome P450 2D6, 3A4, and 2C8, and inhibits cytochrome P450 2D6, while its metabolites also inhibit cytochrome P450 3A in vitro","volume":"51","author":"Paludetto","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2025.106063_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173454","article-title":"Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: role of CYP450 isoforms and epigenetic modulations","volume":"886","author":"Paniri","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.tiv.2025.106063_bb0130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41584-020-00521-x","article-title":"Revisiting the cardiovascular risk of hydroxychloroquine in RA","volume":"16","author":"Pers","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"12","key":"10.1016\/j.tiv.2025.106063_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028943","article-title":"Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in Emiratis","volume":"6","author":"Qumsieh","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.tiv.2025.106063_bb0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","volume":"23","author":"Rainsford","year":"2015","journal-title":"Inflammopharmacology"},{"issue":"14","key":"10.1016\/j.tiv.2025.106063_bb0145","first-page":"1127","article-title":"Metabolism and interactions of chloroquine and hydroxychloroquine with human cytochrome P450 enzymes and drug transporters","volume":"21","author":"Rendic","year":"2020","journal-title":"Curr. Drug Metab."},{"issue":"5","key":"10.1016\/j.tiv.2025.106063_bb0150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1631\/jzus.B2000083","article-title":"An overview of COVID-19","volume":"21","author":"Shi","year":"2020","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.tiv.2025.106063_bb0155","article-title":"Tissue distribution and tumor concentrations of hydroxychloroquine and quinacrine analogs in mice","author":"Solitro","year":"2018","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.tiv.2025.106063_bb0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2125.2000.00197.x","article-title":"Influence of hydroxychloroquine on the bioavailability of oral metoprolol","volume":"49","author":"Somer","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.tiv.2025.106063_bb0165","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1200\/JCO.1994.12.3.532","article-title":"Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors","volume":"12","author":"Sonnichsen","year":"1994","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.tiv.2025.106063_bb0170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bcpt.13124","article-title":"Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomes","volume":"124","author":"Storelli","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.tiv.2025.106063_bb0175","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","volume":"369","author":"Tang","year":"2020","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.tiv.2025.106063_bb0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.1988.tb05281.x","article-title":"A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers","volume":"26","author":"Tett","year":"1988","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.tiv.2025.106063_bb0185","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2125.1989.tb03439.x","article-title":"Bioavailability of hydroxychloroquine tablets in healthy volunteers","volume":"27","author":"Tett","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.tiv.2025.106063_bb0190","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00001813-199607000-00012","article-title":"Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay","volume":"7","author":"Tiberghien","year":"1996","journal-title":"Anti-Cancer Drugs"},{"issue":"3","key":"10.1016\/j.tiv.2025.106063_bb0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/dmd.104.002766","article-title":"Selective inhibition of human cytochrome P4502c8 by Montelukast","volume":"33","author":"Walsky","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.tiv.2025.106063_bb0200","first-page":"897","article-title":"Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro","volume":"29","author":"Zhang","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2025.106063_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.585021","article-title":"Development of a physiologically based pharmacokinetic model for hydroxychloroquine and its application in dose optimization in specific COVID-19 patients","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233325000578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233325000578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T22:26:17Z","timestamp":1750717577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233325000578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":41,"alternative-id":["S0887233325000578"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2025.106063","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Species differences in microsomal metabolism of hydroxychloroquine","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2025.106063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106063"}}